Format

Send to

Choose Destination
Radiother Oncol. 2006 Nov;81(2):163-7. Epub 2006 Oct 16.

Long term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small cell lung carcinoma (NSCLC).

Author information

1
Department of Radiation Oncology, Section of Medical Oncology, Rush University Medical Center, Chicago, IL 60612, USA.

Abstract

We report outcomes on 23 patients with oligometastastic (1 or 2 sites) NSCLC treated with aggressive local, regional, and systemic treatment. The results suggest that this is a favorable subset of patients who may benefit from such an approach, with a 22% rate of long-term survival. This treatment strategy is a departure from the usual practice of palliative-only therapy for all NSCLC patients presenting with metastatic disease.

PMID:
17050016
DOI:
10.1016/j.radonc.2006.09.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center